Geron reported $5.73M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Amgen USD 4.68B 65M Sep/2026
Bio Techne USD 95M 19.5M Jun/2026
Cassava Sciences USD -9.39M 1.78M Jun/2026
Cytokinetics USD -167.09M 12.08M Sep/2026
Exelixis USD 268.42M 20.01M Sep/2026
Genmab DKK 407M 182M Jun/2026
Geron USD 5.73M 18.38M Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
Incyte USD -707.47M 1.41B Sep/2026
MacroGenics USD -13.85M 19.59M Jun/2026
Novartis USD 5.14B 392M Sep/2026
Novavax USD 20.94M 100.32M Dec/2025